Search
Spotlight
The OncLive Insider app is live!
CME Opportunities
The OncLive Insider app is live!
CME Opportunities
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Partners
Publications
Resources
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
The OncLive Insider app is live!
CME Opportunities
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Expanding Treatment Options for HER2+ Breast Cancer
EP. 1: Guidelines and Approaches to HER2 Testing for Breast Cancer
June 30th 2020
EP. 2: HER2+ Early-Stage Breast Cancer
June 30th 2020
EP. 3: APHINITY and ExteNET Trials for Early-Stage Breast Cancer
June 30th 2020
EP. 4: TRAIN-2: Anthracyclines in HER2+ Breast Cancer
June 30th 2020
EP. 5: KAITLIN: T-DM1/Pertuzumab After Anthracycline-Based Adjuvant Therapy
June 30th 2020
EP. 6: HER2+ Early Stage Breast Cancer With Residual Invasive Disease
June 30th 2020
EP. 7: Biomarker Data After Neoadjuvant Therapy for HER2+ Breast Cancer
June 30th 2020
EP. 8: HER2CLIMB: Brain Metastases Data
June 30th 2020
EP. 9: Treatment Choice for Patient Relapsing With Brain Metastases
June 30th 2020
EP. 10: DS-8201 and Tucatinib in HER2+ Metastatic Breast Cancer
June 30th 2020
EP. 11: SOPHIA: Margetuximab + Chemotherapy for RR HER2+ MBC
June 30th 2020
EP. 12: CDK4/6 Inhibitors for Triple-Positive Breast Cancer
June 30th 2020
EP. 13: Impact of Recent Clinical Data on Treatment for HER2+ MBC
June 30th 2020
x